The US government and the Operation Warp Speed goal is to have 300 million doses of a COVID-19 vaccine candidate available in early 2021.
Everything that we’ve done for 22 years has prepared us to make this contribution.
Our partners like Johnson & Johnson and AstraZeneca, they’ve developed these candidates in their facilities, and they are asking us to prepare for large scale manufacturing.
The typical timeline for vaccine development can be anywhere from five to eight years. We’re looking to significantly collapse that timeframe.
That’s the tough part.
Working with Emergent BioSolutions in the midst of this current pandemic is incredibly rewarding.
The people in the labs, they’re working around the clock trying to break records, literally, in developing a vaccine.
Wells Fargo has always taken the time to really understand our business. They know our mission. They know our history. We’re proud to have an organization like Wells at our back.
We have the expertise to manufacture hundreds of millions of doses. We’re going to do what we need to do to race to the finish line.